Anakinra (Kineret -- Amgen) has been approved by FDA for treatment of moderately to severely active rheumatoid arthritis (RA) in adults who have failed one or more disease-modifying antirheumatic ...

U.S. Navy Petty Officer 3rd Class Andre May, a Sailor with Expeditionary Medical Facility-M and a native of Mount Vernon, N.Y., checks a patient’s blood pressure at Baton Rouge General Mid City campus ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Diagnostic workups for patients with interleukin-1 ...

The World Health Organization (WHO) has updated its patient care guidelines to include interleukin-6 receptor blockers, a class of medicines that are lifesaving in patients who are severely or ...

In a recent Cochrane Database of Systematic Reviews study, researchers assess the effectiveness and safety outcomes of interleukin-1 (IL-1) blocking agents in the treatment of coronavirus disease 2019 ...

Researchers have identified a novel strategy to reduce immune-related adverse events from immunotherapy treatment by targeting the cytokine interleukin-6 (IL-6). Researchers at The University of Texas ...

CAR-T cell treatment can have a number of side effects, with the most serious being cytokine release syndrome, according to David L. Porter, MD, of the University of Pennsylvania Health System.

The most common adverse effect seen in clinical trials of anakinra was a reaction at the site of injection -- usually mild swelling, pain, and redness lasting 14 to 28 days. In clinical trials, the ...

HOUSTON ― Researchers at The University of Texas MD Anderson Cancer Center have identified a novel strategy to reduce immune-related adverse events from immunotherapy treatment by targeting the ...